Pill trial aims to delay brain Tumor's return

NCT ID NCT06780930

Ongoing Disease control Sponsor: Servier Source: ClinicalTrials.gov ↗

First seen Jan 11, 2026 · Last updated Apr 23, 2026 · Updated 20 times

Summary

This study is testing whether a daily pill called vorasidenib can slow down or prevent the regrowth of a specific type of slow-growing brain tumor in Asian patients. Participants will take either the study drug or a placebo (sugar pill) and be closely monitored to see how long they live without their tumor getting worse. The goal is to control the disease and delay the need for more surgery or radiation.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RESIDUAL OR RECURRENT GRADE 2 IDH MUTANT GLIOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Chang Gung Memorial Hospital,

Taoyuan District, Taiwan
Huashan Hospital Fudan University

Shanghai, 200040, China
Sanbo Brain Hospital, Capital Medical University

Beijing, China
Taipei Veterans General Hospital

Taipei, Taiwan
The Second Affiliated Hospital of Air Force Military Medical University

Xi'an, China
The Second People's Hospital of Shenzhen

Shenzhen, Guangdong, China
Tiantan Hospital

Beijing, 100070, China
West China Hospital Sichuan University

Chengdu, Sichuan, China

Conditions

Explore the condition pages connected to this study.

RESIDUAL OR RECURRENT GRADE 2 IDH MUTANT GLIOMA